Article Information
History
- February 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Elena María Fernández-Garnacho1,
- Ferran Nadeu1,2,
- Silvia Martín1,
- Pablo Mozas1,3,
- Andrea Rivero1,3,
- Julio Delgado1,2,3,
- Eva Giné1,2,3,
- Armando López-Guillermo1,2,3,
- Martí Duran-Ferrer1,
- Itziar Salaverria1,2,
- Cristina López1,2,
- Sílvia Beà1,2,3,
- Santiago Demajo1,
- Pedro Jares1,2,3,
- Xose S Puente2,4,
- José Ignacio Martín-Subero1,2,5,
- Elias Campo1,2,3,5 and
- Lluís Hernández1,2,*
- 1Lymphoid Neoplasm Program, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
- 2Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
- 3Hospital Clínic of Barcelona, Universitat de Barcelona, Barcelona, Spain
- 4University of Oviedo, Oviedo, Spain
- 5Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
- ↵*Corresponding Author:
Lluís Hernández, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, Barcelona 08036, Spain. Phone: 34-93-2275400, ext.4582; Fax: 34-93-2275717; E-mail: hernan{at}recerca.clinic.cat